Szmit-Domagalska J, Petriczko E, Drozdzynska M, Adler G, Horodnicka-Jozwa A, Ciechanowicz A, Walczak M.
Journal Article 2016; 37(4): 282-288 PubMed PMID: 27857044 Keywords: Case-Control Studies, Child, Exons, Female, Genotype, Growth Disorders:drug therapy, Growth Hormone:therapeutic use, Hormone Replacement Therapy:methods, Human Growth Hormone:deficiency, Humans, Infant, Newborn, Male, Poland, Polymorphism, Genetic, Recept. CitationOBJECTIVES: The human growth hormone receptor (GHR) exon 3 deletion (d3) polymorphism has been reported to be associated with the responsi.....
Szmit-Domagalska J, Petriczko E, Drozdzynska M, Adler G, Horodnicka-Jozwa A, Ciechanowicz A, Walczak M. The impact of the d3-growth hormone receptor (d3-GHR) polymorphism on the therapeutic effect of growth hormone replacement in children with idiopathic growth hormone deficiency in Poland. Neuro Endocrinol Lett. 2016 Sep; 37(4): 282-288
Wilk M, Horodnicka-Józwa A, Moleda P, Petriczko E, Safranow K, Chojnacka H, Gawrych E, Walczak A, Walczak M.
Journal Article 2015; 36(5): 504-510 PubMed PMID: 26707052 Keywords: Adolescent, Birth Weight, Blood Glucose:metabolism, Body Mass Index, C-Peptide:metabolism, Case-Control Studies, Child, Diabetes, Gestational:epidemiology, Female, Glucose Intolerance:epidemiology, Glucose Tolerance Test, Hemoglobin A, Glycosylated:metabo. CitationOBJECTIVES: The study was undertaken to assess the selected carbohydrate parameters in children exposed to gestational diabetes in utero.<.....
Wilk M, Horodnicka-Józwa A, Moleda P, Petriczko E, Safranow K, Chojnacka H, Gawrych E, Walczak A, Walczak M. Assessment of selected carbohydrate parameters in children exposed to gestational diabetes in utero. Neuro Endocrinol Lett. 2015 Jan; 36(5): 504-510
Biczysko-Mokosa A, Petriczko E, Horodnicka-Józwa A, Dawid G, Kedzia A, Lewiński A, Walczak M.
Comparative Study 2014; 35(3): 242-247 PubMed PMID: 24977976 Keywords: Adolescent, Body Height, Child, Dwarfism, Pituitary:drug therapy, Female, Hormone Replacement Therapy, Human Growth Hormone:therapeutic use, Humans, Male, Poland, Prognosis, Recombinant Proteins:therapeutic use, Severity of Illness Index,. CitationOBJECTIVES: The main goal of growth hormone therapy is to reach the height in the population ranges. The aim of the study was the comparis.....
Biczysko-Mokosa A, Petriczko E, Horodnicka-Józwa A, Dawid G, Kedzia A, Lewiński A, Walczak M. Evaluation of final height prediction and selected parameters in Polish patients with severe and partial growth hormone deficiency. Neuro Endocrinol Lett. 2014 Jan; 35(3): 242-247
Petriczko E, Horodnicka-Jozwa A, Grabowska-Wnuk W, Sienko M, Syrenicz A, Walczak M.
Journal Article 2010; 31(4): 559-567 PubMed PMID: 20802451 Keywords: Adipose Tissue:metabolism, Adolescent, Diabetes Mellitus, Type 1:metabolism, Female, Glucose:metabolism, Glycerol:metabolism, Humans, Lactic Acid:metabolism, Male, Microdialysis, Statistics, Nonparametric, Young Adult,. CitationOBJECTIVE: The study was undertaken to assess the interstitial, adipose tissue concentrations of glucose, lactate and glycerol in teenager.....
Petriczko E, Horodnicka-Jozwa A, Grabowska-Wnuk W, Sienko M, Syrenicz A, Walczak M. Interstitial measurements of glucose, glycerol and lactate in adolescents with decompensated type 1 diabetes. Neuro Endocrinol Lett. 2010 Jan; 31(4): 559-567
Jackowski T, Petriczko E, Horodnicka-Jozwa A, Biczysko-Mokosa A, Szalecki M, Walczak M.
Journal Article 2019; 40(4): 169-174 PubMed PMID: 32087092 CitationBACKGROUND: Deletion of the long (q) arm of chromosome 18 causes a rare genetic disease termed 18q- syndrome. This syndrome has v.....
Jackowski T, Petriczko E, Horodnicka-Jozwa A, Biczysko-Mokosa A, Szalecki M, Walczak M. Growth hormone treatment in a patient with deletion of the long arm of chromosome 18: An 8-year observation. Neuro Endocrinol Lett. 2019 Nov; 40(4): 169-174
Petriczko E, Marcinkiewicz K, Prokurat A, Sagan L, Malkowski B, Biczysko-Mokosa A, Horodnicka-Jozwa A, Andrysiak-Mamos E, Syrenicz A, Kostrzeba E, Walczak M.
Case Reports 2022; 43(4): 199-207 PubMed PMID: 36528881 CitationOBJECTIVE: Multiple endocrine neoplasia type 1 (MEN1) is a rare disorder characterized by tumors in various endocrine glands. It is caused.....
Petriczko E, Marcinkiewicz K, Prokurat A, Sagan L, Malkowski B, Biczysko-Mokosa A, Horodnicka-Jozwa A, Andrysiak-Mamos E, Syrenicz A, Kostrzeba E, Walczak M. Rare clinical manifestation of multiple endocrine neoplasia type 1. Neuro Endocrinol Lett. 2022 Nov; 43(4): 199-207